JP2015513544A5 - - Google Patents

Download PDF

Info

Publication number
JP2015513544A5
JP2015513544A5 JP2014559183A JP2014559183A JP2015513544A5 JP 2015513544 A5 JP2015513544 A5 JP 2015513544A5 JP 2014559183 A JP2014559183 A JP 2014559183A JP 2014559183 A JP2014559183 A JP 2014559183A JP 2015513544 A5 JP2015513544 A5 JP 2015513544A5
Authority
JP
Japan
Prior art keywords
chem
glp
compound according
peptide
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014559183A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015513544A (ja
JP6300735B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/053796 external-priority patent/WO2013127779A1/en
Publication of JP2015513544A publication Critical patent/JP2015513544A/ja
Publication of JP2015513544A5 publication Critical patent/JP2015513544A5/ja
Application granted granted Critical
Publication of JP6300735B2 publication Critical patent/JP6300735B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014559183A 2012-03-01 2013-02-26 Glp−1プロドラッグ Active JP6300735B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12157638 2012-03-01
EP12157638.3 2012-03-01
PCT/EP2013/053796 WO2013127779A1 (en) 2012-03-01 2013-02-26 Glp-1 prodrugs

Publications (3)

Publication Number Publication Date
JP2015513544A JP2015513544A (ja) 2015-05-14
JP2015513544A5 true JP2015513544A5 (enExample) 2016-03-03
JP6300735B2 JP6300735B2 (ja) 2018-03-28

Family

ID=47748659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014559183A Active JP6300735B2 (ja) 2012-03-01 2013-02-26 Glp−1プロドラッグ

Country Status (6)

Country Link
US (1) US9452225B2 (enExample)
EP (1) EP2820038B1 (enExample)
JP (1) JP6300735B2 (enExample)
CN (1) CN104185639B (enExample)
ES (1) ES2810153T3 (enExample)
WO (1) WO2013127779A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016343775B2 (en) 2015-10-28 2021-07-29 Tufts Medical Center Novel polypeptides with improved proteolytic stability, and methods of preparing and using same
TWI847306B (zh) 2017-08-24 2024-07-01 丹麥商諾佛 儂迪克股份有限公司 Glp-1組成物及其用途
CN109942696A (zh) * 2017-12-21 2019-06-28 中国药科大学 长效化胰高血糖素样肽-1(glp-1)类似物及其应用
JP7422754B2 (ja) * 2018-10-26 2024-01-26 ノヴォ ノルディスク アー/エス 安定性セマグルチド組成物およびその使用
BR112022013795A2 (pt) 2020-02-18 2022-09-13 Novo Nordisk As Composição farmacêutica líquida, e, kit
CN113336840B (zh) * 2020-03-02 2022-09-23 武汉帕肽生物医药有限责任公司 订书肽、其制备方法和用途
US20210318292A1 (en) * 2020-04-13 2021-10-14 Sensorium Bio, Inc. System and Method to Detect Small Molecules
PE20240630A1 (es) * 2020-11-06 2024-03-26 Novo Nordisk As Profarmacos de glp-1 y usos de los mismos
CN119173275A (zh) 2022-05-10 2024-12-20 诺和诺德股份有限公司 Glp-1多肽的前药及其用途
CN120659805A (zh) * 2023-10-31 2025-09-16 深圳信立泰药业股份有限公司 Glp-1化合物及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61143400A (ja) * 1984-12-17 1986-07-01 Kenji Okawa アクチノマイシンd様ペプチド
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
FR2777283B1 (fr) * 1998-04-10 2000-11-24 Adir Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA04002996A (es) * 2001-10-01 2004-07-15 Lilly Co Eli Peptidicos de tipo glucagon glp1 y tratamiento de insuficiencia respiratoria.
EP2256130B1 (en) 2005-02-02 2013-09-25 Novo Nordisk A/S Novel insulin derivatives
EP2164466A1 (en) 2007-06-01 2010-03-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
ES2672770T3 (es) 2007-09-05 2018-06-18 Novo Nordisk A/S Derivados del péptido-1 similar al glucagón y su uso farmacéutico
CN101220088B (zh) * 2007-09-24 2012-01-25 中国人民解放军第四军医大学 人胰高血糖素样肽-1类似物的融合蛋白及其应用
EP2217701B9 (en) 2007-10-30 2015-02-18 Indiana University Research and Technology Corporation Glucagon antagonists
CA2702289A1 (en) 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Compounds exhibiting glucagon antagonist and glp-1 agonist activity
US20100317057A1 (en) 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
EP2249853A4 (en) * 2008-01-30 2012-12-26 Univ Indiana Res & Tech Corp ESTER BASED PEPTIDE PRODRUGS
KR20110114568A (ko) 2008-12-19 2011-10-19 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 디펩티드 링크된 약효 물질
AU2009327418A1 (en) 2008-12-19 2010-06-24 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
CN104327182B (zh) * 2009-12-16 2020-04-17 诺沃—诺迪斯克有限公司 双酰化glp-1衍生物
EP2588126A4 (en) * 2010-06-24 2015-07-08 Univ Indiana Res & Tech Corp AMID-BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS

Similar Documents

Publication Publication Date Title
JP2015513544A5 (enExample)
RU2012128547A (ru) Дважды ацилированные производные glp-1
JP2013530974A5 (enExample)
JP2011526886A5 (enExample)
JP2017500289A5 (enExample)
JP2013507439A5 (enExample)
JP2018506507A5 (enExample)
RU2015147876A (ru) Пероральная дозированная форма соединений глюкагоноподобного пептида-1
JP2014503526A5 (enExample)
TN2012000215A1 (en) Pharmaceutical compositions comprising a g l p -1 agonist and methionine
JP2013542247A5 (enExample)
JP2018522843A5 (enExample)
MX355361B (es) Derivados de peptido 1 tipo glucagon (glp-1) doblemente acilados.
EP2581376A4 (en) MATRINIC ACID / MATRINE DERIVATIVES AND METHODS OF PREPARATION AND USES THEREOF
RU2016135543A (ru) Новые производные инсулина и их применение в медицине
MY174002A (en) Combination theraphy for the treatment of diabetes
WO2009076173A3 (en) Fluorinated tripeptide hcv serine protease inhibitors
JP2018505146A5 (enExample)
ME02666B (me) Cefalosporin sa kateholskom grupom
WO2008021871A3 (en) Triazolyl acyclic hepatitis c serine protease inhibitors
RU2020109881A (ru) Агонисты рецепторов glp-1/глюкагона в лечении жировой болезни печени и стеатогепатита
JP2016519106A5 (enExample)
JP2016532716A5 (enExample)
WO2011049908A3 (en) Bismacrokyclic compounds as hepatitis c virus inhibitors
FI3229828T3 (fi) Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio